Glenmark Pharmaceuticals has announced the appointment of Anurag Mantri as President. Mantri joins from Jindal Stainless where he served as Executive Director & Group Chief Finance Officer since 2016.
Glenmark also announced that VS Mani, Executive Director & Global Chief Financial Officer of the company, has conveyed his decision to opt for early retirement and has decided to step down from the position with effect from the close of May 26, 2025. However, for a smooth transition, Mani will continue with the Company for some time.
The candidature of Anurag Mantri to the office of Executive Director & Global Chief Financial Officer will be put up before Audit Committee, Nomination & Remuneration Committee and Board of the Company in the ensuing committee meetings/Board meeting for approval and once approved, he will then be appointed as Executive Director and Global Chief Financial Officer.
Anurag has over thirty years of management experience where he has led large-scale enterprise value creation, managed large IPO’s and global compliance, mergers and acquisitions, corporate finance.
He has also had roles of increasing responsibility in treasury, IR, tax and ERP deployment. Anurag began his career with Larsen & Toubro as part of their Corporate Finance & Group Treasury team. Subsequently, he had impactful stints with HCL Technologies as Corporate Treasurer and SRF Limited as Head treasury, Investor Relations and Mergers & Acquisitions respectively. Post which he spent six years with Cairn Energy as their Group Treasurer & Financial Controller and Head Investor Relations.
After this Anurag joined ACME Group (Solar) briefly as their Executive Director, Finance and Strategy & Group Chief Financial Officer before joining Schneider Electric Infrastructure Limited (SEIL) as Chief Financial Officer. He is a qualified chartered accountant and a Bachelor in Commerce from the University of Rajasthan.
